# Effects of Oral Salmon Calcitonin in Human Osteoarthritis

> **NCT00376311** · PHASE2 · TERMINATED · sponsor: **Université Catholique de Louvain** · enrollment: 54 (—)

## Conditions studied

- Osteoarthritis

## Interventions

- **DRUG:** oral salmon calcitonin

## Key facts

- **NCT ID:** NCT00376311
- **Lead sponsor:** Université Catholique de Louvain
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2002-09
- **Primary completion:** —
- **Final completion:** 2004-05
- **Target enrollment:** 54 (—)
- **Last updated:** 2006-09-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00376311

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00376311, "Effects of Oral Salmon Calcitonin in Human Osteoarthritis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00376311. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*